Early diagnosis of acute kidney dysfunction in combined mechanical injury (literature review)

Author:

Ivanov A.1,Gaiduk S.1,Pershko V.1,Petrova E.1

Affiliation:

1. S.M. Kirov Military Medical Academy, Ministry of Defense of Russia; Saint Petersburg

Abstract

The improvement of clinical and laboratory research methods contributes to the timely diagnosis and improvement of the effectiveness of disease therapy, which ensures the preservation of public health, reducing the time of temporary disability and rehabilitation of patients. The evidence base for determining the predictive role of biomarkers of renal dysfunction is small and is available only for a very limited number of substances – some serum proteins, the synthesis of which increases with acute kidney injury, low molecular weight urine proteins, intracellular enzymes of tubular epithelial cells and some other substances. This article provides an overview of modern laboratory methods of early diagnosis of kidney dysfunction in combined mechanical injury.

Publisher

Russian Vrach, Publishing House Ltd.

Reference36 articles.

1. Алексеев А.В., Гильманов А.Ж., Гатиятуллина Р.С. и др. Современные биомаркеры острого повреждения почек. Практическая медицина. 2014; 3 (79): 22–7 [Alexeev A.V., Gilmanov A.J., Gatiatullina R.S. et al. Recent biomarkers of acute renal injury. Practical medicine. 2014; 3 (79): 22–7 (in Russ.)].

2. Веснина Ж.В. Новые и потенциальные биомаркеры острого повреждения почек. Клиническая лабораторная диагностика. 2018; 63 (7): 388–96 [Vesnina Zh.V. New andpotential biomarkers of acute kidney damage. Russian Clinical Laboratory Diagnostics. 2018; 63 (7): 388–96 (in Russ.)]. DOI: 10.1882im69-2084-2018-63-7-388-396

3. Глизер С.Л., Штегман О.А., Петрова М.М. Биомаркеры в прогнозировании неблагоприятных исходов у пациентов с острой декомпенсированной сердечной недостаточностью и почечным повреждением. Комплексные проблемы сердечно-сосудистых заболеваний. 2021; 10 (3): 65–71 [Glizer S.L., Shtegman O.A., Petrova M.M. Biomarkers and the prediction of adverse outcomes in patients with acute decompensated heart failure and kidney injury. Complex Issues of Cardiovascular Diseases. 2021; 10 (3): 65–71 (in Russ.)]. DOI: 10.17802/2306-1278-2021-10-3-65-71

4. Исхакова Р.С. Оценка значимости лабораторных биомаркеров почечного повреждения при нефролитотрипсии. Дисс. … канд. биол. наук. СПб, 2021; 116 с. [Iskhakova R.S. Evaluation of the significance of laboratory biomarkers of renal damage in nephrolithotripsy. Diss. … kand. biol. nauk. St. Petersburg, 2021; 116 p. (in Russ.)].

5. Кобалава Ж.Д., Виллевальде С.В., Ефремовцева М.А. и др. Биомаркеры острого повреждения почек: современные представления и перспективы. Терапевтический архив. 2014; 86 (6): 88–93 [Kobalava Zh.D., Villeval'de S.V., Efremovtseva M.A. et al. Biomarkers of acute kidney injury: Current views and prospects. Therapeutic Archive. 2014; 86 (6): 88–93 (in Russ.)].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3